← Open Payments lookup

LILIAN OGUJIOFOR: Open Payments

NPI 1255635058 · LANSDOWNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,807 in 74 payments from 17 companies in 2025. Trend: 2023 $1,766 · 2024 $2,705 · 2025 $3,807

Food & beverage: $3,807
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$742
Vanda Pharmaceuticals Inc.7$565
Otsuka America Pharmaceutical, Inc.10$483
ABBVIE INC.20$381
Neurocrine BioSciences, Inc.4$290
Axsome Therapeutics, Inc.3$262
Janssen Pharmaceuticals, Inc5$251
Teva Pharmaceuticals USA, Inc.2$244
E.R. Squibb & Sons, L.L.C.3$227
Alkermes, Inc.2$148

Products named: CAPLYTA, FANAPT, REXULTI, VRAYLAR, INGREZZA, Auvelity, AUSTEDO XR, COBENFY.

Industry payments across PA — which companies pay providers there.